| RHIV A Pilot Study Refractory or Intolerant to Highly Active Antiretroviral Therapy (HAART) (NCT00157027) | Atlantic Health System | 2003-12-01 |
| Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults (NCT00071851) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-12-01 |
| ARVs to Prevent Breastmilk HIV:Viral and Immune Responses (NCT00167674) | University of Washington | 2003-11-03 |
| Pharmacokinetics and Safety Study of Tipranavir in Combination With Low Dose Ritonavir in Human Immunodeficiency Virus (HIV)-Infected Children (NCT00076999) | Boehringer Ingelheim | 2003-11-01 |
| Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C (NCT00122616) | French National Agency for Research on AIDS and Viral Hepatitis | 2003-11-01 |
| ALCAR Prophylaxis Study (NCT00225160) | Royal Free Hampstead NHS Trust | 2003-11-01 |
| Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients (NCT00122668) | French National Agency for Research on AIDS and Viral Hepatitis | 2003-11-01 |
| An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ Subjects (NCT00144261) | Boehringer Ingelheim | 2003-11-01 |
| Effectiveness of a Risk Reduction Program in Preventing the Transmission of HIV and Sexually Transmitted Diseases in African-American Couples (NCT00644163) | University of Pennsylvania | 2003-11-01 |
| Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects (NCT00071760) | ViiV Healthcare | 2003-10-23 |
| Viral Load Determination and Biomarkers of High Risk Human Papillomavirus (HPV) - Types in HIV-positive Men (NCT00365729) | Deutsche Luft und Raumfahrt | 2003-10-01 |
| Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions (NCT00152815) | Johane Allard | 2003-10-01 |
| Study on the Effect of Kaletra + Nevirapine as Maintenance Bitherapy Compared to a Triple Therapy Including Kaletra + Analogues in HIV Patients (NCT00335686) | Germans Trias i Pujol Hospital | 2003-10-01 |
| A PK and Salvage Study for Children With HIV-infection (NCT00476359) | The HIV Netherlands Australia Thailand Research Collaboration | 2003-10-01 |
| Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults (NCT00051831) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-10-01 |
| An Effective Alternative to the Standard Referral System for HIV Testing in the Emergency Department During Off Hour Tours: A Randomized Trial (NCT00218881) | North Bronx Healthcare Network | 2003-10-01 |
| Phase I/II, Open-Label Trial of Three Monoclonal Antibodies (NCT00219986) | Rockefeller University | 2003-10-01 |
| Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx (NCT00071890) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-10-01 |
| An Electronic Pillbox for People With HIV (NCT00071500) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-10-01 |
| Kidney and Liver Transplantation in People With HIV (NCT00074386) | University of California, San Francisco | 2003-10-01 |
| TMC114-C202: A Study of Safety, Efficacy, and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients (NCT00071097) | Tibotec Pharmaceuticals, Ireland | 2003-10-01 |
| A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth (NCT00069004) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-10-01 |
| RCT of Russian IDU Peer Network HIV Prevention Intervention - 1 (NCT00218673) | Johns Hopkins Bloomberg School of Public Health | 2003-10-01 |
| Evaluation of an HIV Outreach Program (NCT00300183) | Montefiore Medical Center | 2003-10-01 |
| Improving Provider Counseling Interventions in HIV Practice (NCT00538993) | Johns Hopkins University | 2003-09-01 |
| Immune Response to Influenza Vaccine in HIV-Infected Individuals (NCT00069914) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-09-01 |
| Partnership on Nutrition and HIV/AIDS Research in Tanzania: Exploratory Research Study on Selenium and HIV Infection (NCT00197561) | Harvard School of Public Health (HSPH) | 2003-09-01 |
| Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection (NCT00801879) | Columbia University | 2003-09-01 |
| Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the Community (NCT00124878) | Wawer, Maria J., M.D. | 2003-08-01 |
| Safety of the EnvPro HIV Vaccine in Healthy Volunteers (NCT00076947) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-08-01 |
| Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (NCT00064623) | NeurogesX | 2003-08-01 |
| Influence of Chloroquine on HIV Viral Load Among Pregnant Women in Uganda (NCT00132535) | London School of Hygiene and Tropical Medicine | 2003-08-01 |
| Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection (NCT00205283) | University of Wisconsin, Madison | 2003-08-01 |
| Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting (NCT00642499) | Solvay Pharmaceuticals | 2003-08-01 |
| Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Between Older and Younger HIV-Infected Adults (NCT00179335) | Albert Einstein College of Medicine | 2003-08-01 |
| Safety of an HIV Vaccine (AVX101) in HIV Uninfected Volunteers in the United States and South Africa (NCT00063778) | AlphaVax, Inc. | 2003-07-01 |
| Long-term Follow-up of HIV Infected Patients Identified During Early Infection (NCT00086372) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-07-01 |
| Metabolic Abnormalities in HIV Infected and Uninfected Young Women (NCT00067587) | University of North Carolina, Chapel Hill | 2003-07-01 |
| Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects (NCT00112047) | Gilead Sciences | 2003-07-01 |
| 4-Day-A-Week Treatment Plan for HIV Infected Adolescents (NCT00068809) | University of North Carolina, Chapel Hill | 2003-07-01 |
| Treatment Plan to Decrease Drug Exposure in HIV Infected Adolescents (NCT00067574) | University of North Carolina, Chapel Hill | 2003-07-01 |
| A Study of Zidovudine/Lamivudine and Either Nevirapine or Nelfinavir for Reduction of Mother-to-child HIV Transmission During Breastfeeding (NCT00146380) | Centers for Disease Control and Prevention | 2003-07-01 |
| Antiviral Therapy and HIV in the Female Genital Tract (NCT00067106) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-07-01 |
| Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy (NCT00042289) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-06-09 |
| A Tailored Interactive Website for Promoting Condom Use Among Young Adults (NCT00183638) | University of Colorado, Denver | 2003-06-01 |
| Safety and Durability ofTenofovir and a Cell Cycle Agent for Viral Suppression (NCT00344981) | University of Maryland, Baltimore | 2003-06-01 |
| Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels (NCT00143624) | University of British Columbia | 2003-06-01 |
| The Effects of Nutritional Supplementation and Drug Abuse on HIV (NCT00149656) | Florida International University | 2003-06-01 |
| Bioequivalency Study of Zidovudine Under Fed Conditions (NCT00601562) | Roxane Laboratories | 2003-06-01 |
| Education Program to Promote Female Condom Use (NCT00062634) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2003-06-01 |
| A Worldwide, Phase I, Dose-Escalating Study of a 3-Dose Regimen of the MRKAd5 (Clade B) Vaccine in Healthy Adults (V520-018) (NCT00849732) | Merck Sharp & Dohme LLC | 2003-06-01 |
| Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia (NCT00405171) | University Hospital, Caen | 2003-06-01 |
| Bioequivalency Study of Zidovudine Under Fasting Conditions (NCT00602550) | Roxane Laboratories | 2003-06-01 |
| Study of HIV-1 Rgp-160 Administered by Mucosal Routes in Healthy Volunteers (NCT00122564) | French National Agency for Research on AIDS and Viral Hepatitis | 2003-06-01 |
| An Educational HIV Pre-Test Counseling Video Program for Off Hours Testing in the ED: A Randomized Control Trial (NCT00218907) | North Bronx Healthcare Network | 2003-06-01 |
| Home-based AIDS Care Project (NCT00119093) | Centers for Disease Control and Prevention | 2003-05-01 |
| Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection (NCT00062660) | Boehringer Ingelheim | 2003-05-01 |
| Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy (NCT00127569) | French National Agency for Research on AIDS and Viral Hepatitis | 2003-05-01 |
| Cohort Study for Patients Using Fuzeon (Enfuvirtide) (NCT00216359) | Institute for Interdisciplinary Infectiology | 2003-05-01 |
| Curb, Alter, Lower, or Manage Stress in HIV: CALMS-HIV (NCT00057538) | National Center for Complementary and Integrative Health (NCCIH) | 2003-05-01 |
| A Study to Prepare for Future HIV Vaccine Studies (NCT00029744) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-04-01 |
| A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults (V520-016) (NCT00849680) | Merck Sharp & Dohme LLC | 2003-04-01 |
| Pediatric Impact: Promoting Adherence to Medications Among HIV-infected Children (NCT00134602) | Centers for Disease Control and Prevention | 2003-04-01 |
| Analysis of Immune Responses to HIV Vaccines (NCT00068978) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-04-01 |
| Therapeutic Schools: Affect Management and HIV Prevention (NCT00500487) | Rhode Island Hospital | 2003-04-01 |
| A Phase IIA Trial to Evaluate the Safety and Immunogenicity of a DNA HIV-1 Vaccine Followed by an MVA HIV-1 Vaccine in HIV-uninfected Volunteers (NCT01371175) | International AIDS Vaccine Initiative | 2003-04-01 |
| Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients (NCT00196586) | French National Agency for Research on AIDS and Viral Hepatitis | 2003-04-01 |
| Safety and Efficacy of PRO 542 in the Treatment of HIV-Infected Patients (NCT00055185) | Progenics Pharmaceuticals, Inc. | 2003-04-01 |
| Safety and Efficacy of Zinc Supplementation in HIV-1-Infected Children in South Africa (NCT00138047) | Johns Hopkins Bloomberg School of Public Health | 2003-03-01 |
| FREE Study: Efficacy and Toxicity of Trizivir (NCT00405925) | Rijnstate Hospital | 2003-03-01 |
| Massage to Increase Well-Being and Immune Function in Dominican Children Infected With HIV (NCT00070980) | National Center for Complementary and Integrative Health (NCCIH) | 2003-03-01 |
| When to Start Anti-HIV Drugs in Patients With Opportunistic Infections (NCT00055120) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-03-01 |
| A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons (NCT00161434) | University of Washington | 2003-03-01 |
| Immunologic Control of Drug Resistant HIV (NCT00053404) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-03-01 |
| Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults (NCT00051454) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-03-01 |
| A Prospective Cohort of Children With HIV Infection (NCT00476606) | The HIV Netherlands Australia Thailand Research Collaboration | 2003-03-01 |
| Experimental Design of Couple Counseling and Testing in Antenatal Clinics in Dar es Salaam, Tanzania (NCT00631384) | Johns Hopkins Bloomberg School of Public Health | 2003-03-01 |
| A Randomized, Controlled, Cross-Over Trial of Safety of Vaginal Use of Carraguard by HIV-Infected Women (NCT00213044) | Population Council | 2003-03-01 |
| Tenofovir DF + Efavirenz (TDF+EFV) Versus Tenofovir DF + Efavirenz + Lamivudine (TDF+EFV+3TC) Maintenance Regimen in Virologically Controlled Patients: COOL Trial (NCT00643968) | Gilead Sciences | 2003-03-01 |
| Stepping Stones Program for Preventing HIV Infection in Residents of Rural South African Communities (NCT00332878) | Medical Research Council, South Africa | 2003-03-01 |
| Safety Study of Once a Day ART and Opiate Substitute. (NCT00324688) | Gilead Sciences | 2003-03-01 |
| Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus (NCT00102934) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-03-01 |
| Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients (NCT00055237) | National Cancer Institute (NCI) | 2003-02-26 |
| Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients (NCT00056641) | Boehringer Ingelheim | 2003-02-18 |
| Could Dietary Algae Affect Immunity and Viral Counts in People With HIV? (NCT01195077) | University of South Carolina | 2003-02-01 |
| Evaluation of Enrollment, Dynamics of Care and Patient Outcomes in the NYS Medicaid HIV Special Needs Plans (NCT00577811) | Memorial Sloan Kettering Cancer Center | 2003-02-01 |
| Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients (NCT00148850) | French National Agency for Research on AIDS and Viral Hepatitis | 2003-02-01 |
| Long-Term Supervised Treatment Interruption in HIV-Infected Patients (NCT00118677) | French National Agency for Research on AIDS and Viral Hepatitis | 2003-02-01 |
| Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV (NCT00006441) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-02-01 |
| HIV Prevention Within High-Risk Bulgarian and Hungarian Social Networks (NCT00310973) | Medical College of Wisconsin | 2003-02-01 |
| Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2) (NCT00144170) | Boehringer Ingelheim | 2003-02-01 |
| Antibody Responses to Pneumococcal Vaccines Among HIV-infected Adults. (NCT00148824) | ANRS, Emerging Infectious Diseases | 2003-02-01 |
| Family Access to Care Study (FACS) (NCT00582218) | Memorial Sloan Kettering Cancer Center | 2003-02-01 |
| HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs (NCT00056758) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-02-01 |
| Marijuana for HIV-Related Peripheral Neuropathy (NCT00046722) | Center for Medicinal Cannabis Research | 2003-01-01 |
| MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS) (NCT00122226) | Amsterdam UMC, location VUmc | 2003-01-01 |
| Modified Directly Observed Therapy for Improving Antiretroviral Therapy Adherence in People With HIV (NCT00339092) | Massachusetts General Hospital | 2003-01-01 |
| Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST) (NCT00054717) | Boehringer Ingelheim | 2003-01-01 |
| Therapeutic Approaches to HAART-Induced Lipodystrophy (NCT00461552) | University of Texas Southwestern Medical Center | 2003-01-01 |
| A Network Intervention for Prevention of HIV Infection in Chennai, India - 1 (NCT00218686) | Johns Hopkins Bloomberg School of Public Health | 2003-01-01 |